Tang Capital Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.09M | Hold |
1,867,773
| – | – | 0.11% | 115 |
|
|
2025
Q1 | $1.48M | Buy |
1,867,773
+11,819
| +0.6% | +$9.34K | 0.08% | 136 |
|
|
2024
Q4 | $3.06M | Buy |
1,855,954
+1,155,954
| +165% | +$1.91M | 0.2% | 91 |
|
|
2024
Q3 | $2.45M | Hold |
700,000
| – | – | 0.18% | 92 |
|
|
2024
Q2 | $2.3M | Hold |
700,000
| – | – | 0.23% | 75 |
|
|
2024
Q1 | $5.14M | Hold |
700,000
| – | – | 0.54% | 57 |
|
|
2023
Q4 | $2.62M | Hold |
700,000
| – | – | 0.24% | 83 |
|
|
2023
Q3 | $1.48M | Hold |
700,000
| – | – | 0.21% | 85 |
|
|
2023
Q2 | $3.33M | Hold |
700,000
| – | – | 0.49% | 56 |
|
|
2023
Q1 | $3.99M | Buy |
+700,000
| New | +$3.99M | 0.59% | 46 |
|